Sessa Capital Im, L.P. Bristol Myers Squibb CO Transaction History

Sessa Capital Im, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$50.53 - $62.98 $1.53 Million - $1.91 Million	-30,300 Reduced 17.31%	144,700 $8.01 Million
Q1 2018 May 15, 2018	SELL	$59.92 - $68.98 $1.5 Million - $1.72 Million	-25,000 Reduced 12.5%	175,000 $11.1 Million
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $11 Million - $12.7 Million	200,000	200,000 $12.7 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Sessa Capital Im, L.P., based on Form 13F filings with the SEC.

Stay updated on Sessa Capital Im, L.P. with notifications on news.